ArticleVirology2014

Escape from neutralization by the respiratory syncytial virus-specific neutralizing monoclonal antibody palivizumab is driven by changes in on-rate of binding to the fusion protein.

John T Bates et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.